Patent Board Turns Away Challenge To Cancer Drug In Final Decision

(October 6, 2017, 4:30 PM EDT) -- ALEXANDRIA, Va. — A consolidated challenge to 22 claims of the patented cancer drug Alimta was rejected Oct. 5 by the Patent Trial and Appeal Board, which found that various petitions...
To view the full article, register now.